Gainers

• Ensysce Biosciences (NASDAQ:ENSC) shares rose 40.4% to $0.55 during Friday's pre-market session. The market value of their outstanding shares is at $1.3 million.
• Cardio Diagnostics Hldgs (NASDAQ:CDIO) stock rose 23.18% to $6.43. The market value of their outstanding shares is at $9.5 million.
• Neurogene (NASDAQ:NGNE) shares rose 20.93% to $23.8. The company's market cap stands at $304.8 million.
• Caris Life Sciences (NASDAQ:CAI) stock increased by 14.81% to $22.09. The market value of their outstanding shares is at $5.4 billion. As per the press release, Q4 earnings came out yesterday.
• BioAtla (NASDAQ:BCAB) shares moved upwards by 10.78% to $0.26. The market value of their outstanding shares is at $17.6 million.
• Candel Therapeutics (NASDAQ:CADL) stock increased by 8.73% to $5.6. The company's market cap stands at $282.7 million.

Losers

• Emergent BioSolutions (NYSE:EBS) stock decreased by 21.8% to $8.68 during Friday's pre-market session. The company's market cap stands at $582.9 million. As per the news, the Q4 earnings report came out yesterday.
• XORTX Therapeutics (NASDAQ:XRTX) shares fell 17.58% to $0.33. The market value of their outstanding shares is at $2.8 million.
• Ginkgo Bioworks Holdings (NYSE:DNA) stock declined by 16.69% to $8.09. The market value of their outstanding shares is at $588.3 million. As per the press release, Q4 earnings came out yesterday.
• Fortrea Holdings (NASDAQ:FTRE) shares declined by 13.43% to $9.35. The market value of their outstanding shares is at $997.9 million. As per the news, the Q4 earnings report came out yesterday.
• Amphastar Pharma (NASDAQ:AMPH) shares fell 13.18% to $23.0. The company's market cap stands at $1.2 billion. The company's, Q4 earnings came out yesterday.
• Seer (NASDAQ:SEER) stock declined by 12.99% to $1.81. The company's market cap stands at $117.0 million. As per the press release, Q4 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

• No comments yet. Be the first to comment!